PORTEC 2, 2010

Question 1

Study question for PORTEC 2?

Answer 1

If vaginal recurrence is most frequent site, what can prevent? Is the less option VBT = EBRT but with the benefit

Question 2

Study design PORTEC 2?

Answer 2

Non inferior, RCT; pelvic RT or VBT, vaginal recurrence was outcome

Question 3

Inclusion criteria PORTEC-2?

Answer 3

Stage 1 or IIA endometrial carcinoma with HIR features

Question 4

Results of PORTEC-2?

Answer 4

VBT non inferior; less GI side effects